180 Life Sciences Corp.

Historical 13F Holders

Symbol
ATNF
CUSIP
68236V203
All holders as of
Q1 2024
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 68236V203 since 12/18/2024, newest first.

Filer % of Class Filed
Anson Funds Management LP 13G/A Amendment 1
4.5% 5/15/2025
Event 3/31/2025
Anson Funds Management LP 13G
7.1% 2/14/2025
Event 12/31/2024
Ayrton Capital LLC 13G
9.9% 2/13/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q1 1 1.00 k $195.00
2023 Q4 22 702 k $149 k
2023 Q3 21 722 k $438 k
2023 Q2 13 169 k $197 k
2023 Q1 17 221 k $398 k
2022 Q4 21 174 k $588 k